These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 36077694)
1. Homologous Recombination Deficiency Scar: Mutations and Beyond-Implications for Precision Oncology. van der Wiel AMA; Schuitmaker L; Cong Y; Theys J; Van Hoeck A; Vens C; Lambin P; Yaromina A; Dubois LJ Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077694 [TBL] [Abstract][Full Text] [Related]
2. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types. Takamatsu S; Brown JB; Yamaguchi K; Hamanishi J; Yamanoi K; Takaya H; Kaneyasu T; Mori S; Mandai M; Matsumura N JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34423229 [TBL] [Abstract][Full Text] [Related]
3. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types. Takamatsu S; Brown JB; Yamaguchi K; Hamanishi J; Yamanoi K; Takaya H; Kaneyasu T; Mori S; Mandai M; Matsumura N JCO Precis Oncol; 2022 May; 6():e2200085. PubMed ID: 35613413 [TBL] [Abstract][Full Text] [Related]
4. Biomarkers for Homologous Recombination Deficiency in Cancer. Hoppe MM; Sundar R; Tan DSP; Jeyasekharan AD J Natl Cancer Inst; 2018 Jul; 110(7):704-713. PubMed ID: 29788099 [TBL] [Abstract][Full Text] [Related]
5. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes. Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740 [TBL] [Abstract][Full Text] [Related]
6. Detection and therapeutic implications of homologous recombination repair deficiency in pancreatic cancer: a narrative review. Tan H; Hosein PJ J Gastrointest Oncol; 2023 Oct; 14(5):2249-2259. PubMed ID: 37969835 [TBL] [Abstract][Full Text] [Related]
7. RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox? van Wijk LM; Nilas AB; Vrieling H; Vreeswijk MPG Expert Rev Mol Diagn; 2022 Feb; 22(2):185-199. PubMed ID: 34913794 [TBL] [Abstract][Full Text] [Related]
8. Homologous Recombination Abnormalities Associated With Albitar M; Zhang H; Pecora A; Waintraub S; Graham D; Hellmann M; McNamara D; Charifa A; De Dios I; Ma W; Goy A Breast Cancer (Auckl); 2023; 17():11782234231198979. PubMed ID: 37789896 [TBL] [Abstract][Full Text] [Related]
9. Functional Meijer TG; Verkaik NS; Sieuwerts AM; van Riet J; Naipal KAT; van Deurzen CHM; den Bakker MA; Sleddens HFBM; Dubbink HJ; den Toom TD; Dinjens WNM; Lips E; Nederlof PM; Smid M; van de Werken HJG; Kanaar R; Martens JWM; Jager A; van Gent DC Clin Cancer Res; 2018 Dec; 24(24):6277-6287. PubMed ID: 30139880 [TBL] [Abstract][Full Text] [Related]
10. The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair. Pacheco-Barcia V; Muñoz A; Castro E; Ballesteros AI; Marquina G; González-Díaz I; Colomer R; Romero-Laorden N Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740616 [No Abstract] [Full Text] [Related]
11. Characterization, Detection, and Treatment Approaches for Homologous Recombination Deficiency in Cancer. O'Kane GM; Connor AA; Gallinger S Trends Mol Med; 2017 Dec; 23(12):1121-1137. PubMed ID: 29133135 [TBL] [Abstract][Full Text] [Related]
12. Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort. Leibowitz BD; Dougherty BV; Bell JSK; Kapilivsky J; Michuda J; Sedgewick AJ; Munson WA; Chandra TA; Dry JR; Beaubier N; Igartua C; Taxter T BMC Cancer; 2022 May; 22(1):587. PubMed ID: 35643464 [TBL] [Abstract][Full Text] [Related]
13. A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer. Shao C; Chang MS; Lam FC; Marley AR; Tang H; Song Y; Miller C; Brown M; Wan I; Han J; Adeboyeje G J Oncol; 2022; 2022():5830475. PubMed ID: 35909902 [TBL] [Abstract][Full Text] [Related]
14. Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors. Ma J; Shah R; Bell AC; McDermott N; Pei X; Selenica P; Haseltine J; Delsite R; Khan AJ; Lok BH; Ellis MJ; Aft RF; Setton J; Reis-Filho JS; Riaz N; Powell SN Int J Radiat Oncol Biol Phys; 2024 Jul; ():. PubMed ID: 38997095 [TBL] [Abstract][Full Text] [Related]
15. [Homologous recombination repair deficiency as a predictive biomarker : Basic mechanisms and detection methods]. Pfarr N; Merkelbach-Bruse S Pathologe; 2021 Jul; 42(4):391-398. PubMed ID: 34152463 [TBL] [Abstract][Full Text] [Related]
16. Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis. Casolino R; Paiella S; Azzolina D; Beer PA; Corbo V; Lorenzoni G; Gregori D; Golan T; Braconi C; Froeling FEM; Milella M; Scarpa A; Pea A; Malleo G; Salvia R; Bassi C; Chang DK; Biankin AV J Clin Oncol; 2021 Aug; 39(23):2617-2631. PubMed ID: 34197182 [TBL] [Abstract][Full Text] [Related]